Physician profile
Ravi Rajaram
NPI 1104137231
$15,677.60
in general payments reported to CMS, 2019-2025
6 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,640 · 2020: $3,035 · 2023: $1,416 · 2024: $9,050 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Travel and Lodging: $1,385 · Food and Beverage: $867 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Travel and Lodging | $1,384.99 |
| Food and Beverage | $867.07 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,270.40 | 2019-2024 | Da Vinci Surgical System |
| Cook Incorporated | $750.00 | 2024 | |
| Atricure, INC. | $432.68 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System, Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $121.29 | 2019 | |
| Ossdsign USA Incorporated | $81.25 | 2025 | Ossdsign Catalyst |
| Acist Medical Systems, INC. | $21.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Rajaram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.